RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Background/Aims: Many patients with Crohn’s disease (CD) undergo intestinal resection during the disease course. Despite surgery, postoperative recurrence (POR) commonly occurs. Although postoperative use of tumor necrosis factor α (TNF-α) inhibitors is known to be effective in preventing POR, few studies have evaluated the effectiveness of continuing the same TNF-α inhibitors postoperatively in patients who received TNF-ɑ inhibitors before surgery.
Methods: This retrospective observational study was performed in a single tertiary medical center.
We retrospectively reviewed patients who had undergone the first intestinal resection due to CD and divided them into two groups: TNF-α inhibitor users in both the preoperative and postoperative periods, and TNF-α inhibitor users in only the preoperative period. We compared the clinical outcomes between these two groups.
Results: In total, 45 patients who used TNF-α inhibitors preoperatively were recruited. Among them, TNF-α inhibitors were used postoperatively in 20 patients (44.4%). The baseline characteristics except age at diagnosis were similar in both groups. The rates of surgical and endoscopic recurrence were not different between the two groups, but the cumulative clinical recurrence rate was significantly lower in the postoperative TNF-α inhibitors group (log-rank p=0.003). In multivariate Cox regression analysis, postoperative TNF-α inhibitors use was significantly associated with a decreased risk of clinical recurrence (adjusted hazard ratio, 0.204; 95% confidence interval, 0.060 to 0.691; p=0.011).
Conclusions: Continuing TNF-α inhibitors postoperatively in patients who were receiving TNF-α inhibitors before surgery significantly reduced the rate of clinical recurrence. For patients with CD who received TNF-α inhibitors preoperatively, continuing their use after surgery could be recommended.

참고문헌 (Reference)

1 D’Haens GR, "Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease : a controlled randomized trial" 135 : 1123-1129, 2008

2 Kulaylat AN, "The impact of preoperative anti-TNFα therapy on postoperative outcomes following ileocolectomy in Crohn’s disease" 25 : 467-474, 2021

3 Fraser AG, "The efficacy of azathioprine for the treatment of inflammatory bowel disease : a 30year review" 50 : 485-489, 2002

4 Satsangi J, "The Montreal classification of inflammatory bowel disease : controversies, consensus, and implications" 55 : 749-753, 2006

5 Ferrante M, "Systematic versus endoscopy-driven treatment with azathioprine to prevent postoperative ileal Crohn’s disease recurrence" 9 : 617-624, 2015

6 Jones GR, "Systematic review : the use of thiopurines or anti-TNF in post-operative Crohn’s disease maintenance. Progress and prospects" 39 : 1253-1265, 2014

7 Sung Bae Kim ; Jae Hee Cheon ; Jae Jun Park ; Eun Soo Kim ; Seong Woo Jeon ; Sung-Ae Jung ; Dong Il Park ; Chang Kyun Lee ; Jong Pil Im ; You Sun Kim ; Hyun Soo Kim ; Jun Lee ; Chang Soo Eun ; Jeong Mi Lee ; Byung Ik Jang ; Geom Seog Seo, "Risk Factors for Postoperative Recurrence in Korean Patients with Crohn’s Disease" 거트앤리버 소화기연관학회협의회 14 (14): 331-337, 2020

8 Buisson A, "Review article : the natural history of postoperative Crohn’s disease recurrence" 35 : 625-633, 2012

9 Emiko Mizoguchi ; Daren Low ; Yui Ezaki ; Toshiyuki Okada, "Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models" 대한장연구학회 18 (18): 151-167, 2020

10 Armuzzi A, "Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn’s disease : an open-label pilot study" 7 : e623-e629, 2013